Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17C

• Kailyn Valido, BS,
• Michael J. Murphy, BS,
• Jonathan S. Leventhal, MD,
• William Damsky, MD, PhD

Affiliations

Kailyn Valido, BS

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut

Michael J. Murphy, BS

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut

Jonathan S. Leventhal, MD

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut

William Damsky, MD, PhD

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut; Department of Pathology, Yale School of Medicine, New Haven, Connecticut; Correspondence to: William Damsky, MD, PhD, Department of Dermatology and Pathology, Yale School of Medicine, 333 Cedar St, LCI 501, PO Box 208059, New Haven, CT 06510.